Advances in bioinks and in vivo imaging of biomaterials for CNS applications

Eduarda P. Oliveira, Izabela Malysz-Cymborska, Dominika Golubczyk, Lukasz Kalkowski, Joanna Kwiatkowska, Rui L. Reis, J. Miguel Oliveira, Piotr Walczak

Research output: Contribution to journalReview article

Abstract

Due to increasing life expectancy incidence of neurological disorders is rapidly rising, thus adding urgency to develop effective strategies for treatment. Stem cell-based therapies were considered highly promising and while progress in this field is evident, outcomes of clinical trials are rather disappointing. Suboptimal engraftment, poor cell survival and uncontrolled differentiation may be the reasons behind dismal results. Clearly, new direction is needed and we postulate that with recent progress in biomaterials and bioprinting, regenerative approaches for neurological applications may be finally successful. The use of biomaterials aids engraftment of stem cells, protects them from harmful microenvironment and importantly, it facilitates the incorporation of cell-supporting molecules. The biomaterials used in bioprinting (the bioinks) form a scaffold for embedding the cells/biomolecules of interest, but also could be exploited as a source of endogenous contrast or supplemented with contrast agents for imaging. Additionally, bioprinting enables patient-specific customization with shape/size tailored for actual needs. In stroke or traumatic brain injury for example lesions are localized and focal, and usually progress with significant loss of tissue volume creating space that could be filled with artificial tissue using bioprinting modalities. The value of imaging for bioprinting technology is advantageous on many levels including design of custom shapes scaffolds based on anatomical 3D scans, assessment of performance and integration after scaffold implantation, or to learn about the degradation over time. In this review, we focus on bioprinting technology describing different printing techniques and properties of biomaterials in the context of requirements for neurological applications. We also discuss the need for in vivo imaging of implanted materials and tissue constructs reviewing applicable imaging modalities and type of information they can provide. Statement of Significance: Current stem cell-based regenerative strategies for neurological diseases are ineffective due to inaccurate engraftment, low cell viability and suboptimal differentiation. Bioprinting and embedding stem cells within biomaterials at high precision, including building complex multi-material and multi-cell type composites may bring a breakthrough in this field. We provide here comprehensive review of bioinks, bioprinting techniques applicable to application for neurological disorders. Appreciating importance of longitudinal monitoring of implanted scaffolds, we discuss advantages of various imaging modalities available and suitable for imaging biomaterials in the central nervous system. Our goal is to inspire new experimental approaches combining imaging, biomaterials/bioinks, advanced manufacturing and tissue engineering approaches, and stimulate interest in image-guided therapies based on bioprinting.

Original languageEnglish (US)
JournalActa Biomaterialia
DOIs
StatePublished - Jan 1 2019

Fingerprint

Bioprinting
Biocompatible Materials
Biomaterials
Imaging techniques
Stem cells
Scaffolds
Stem Cells
Tissue
Nervous System Diseases
Cells
Cell Survival
Forms (concrete)
Neurology
Biomolecules
Scaffolds (biology)
Technology
Tissue engineering
Printing
Ion implantation
Contrast Media

Keywords

  • Bioink
  • Bioprinting
  • Brain
  • Imaging
  • Stem cells

ASJC Scopus subject areas

  • Biotechnology
  • Biomaterials
  • Biochemistry
  • Biomedical Engineering
  • Molecular Biology

Cite this

Oliveira, E. P., Malysz-Cymborska, I., Golubczyk, D., Kalkowski, L., Kwiatkowska, J., Reis, R. L., ... Walczak, P. (2019). Advances in bioinks and in vivo imaging of biomaterials for CNS applications. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2019.05.006

Advances in bioinks and in vivo imaging of biomaterials for CNS applications. / Oliveira, Eduarda P.; Malysz-Cymborska, Izabela; Golubczyk, Dominika; Kalkowski, Lukasz; Kwiatkowska, Joanna; Reis, Rui L.; Oliveira, J. Miguel; Walczak, Piotr.

In: Acta Biomaterialia, 01.01.2019.

Research output: Contribution to journalReview article

Oliveira, EP, Malysz-Cymborska, I, Golubczyk, D, Kalkowski, L, Kwiatkowska, J, Reis, RL, Oliveira, JM & Walczak, P 2019, 'Advances in bioinks and in vivo imaging of biomaterials for CNS applications', Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2019.05.006
Oliveira EP, Malysz-Cymborska I, Golubczyk D, Kalkowski L, Kwiatkowska J, Reis RL et al. Advances in bioinks and in vivo imaging of biomaterials for CNS applications. Acta Biomaterialia. 2019 Jan 1. https://doi.org/10.1016/j.actbio.2019.05.006
Oliveira, Eduarda P. ; Malysz-Cymborska, Izabela ; Golubczyk, Dominika ; Kalkowski, Lukasz ; Kwiatkowska, Joanna ; Reis, Rui L. ; Oliveira, J. Miguel ; Walczak, Piotr. / Advances in bioinks and in vivo imaging of biomaterials for CNS applications. In: Acta Biomaterialia. 2019.
@article{99247c8d428c4ca18d84476db3507d0f,
title = "Advances in bioinks and in vivo imaging of biomaterials for CNS applications",
abstract = "Due to increasing life expectancy incidence of neurological disorders is rapidly rising, thus adding urgency to develop effective strategies for treatment. Stem cell-based therapies were considered highly promising and while progress in this field is evident, outcomes of clinical trials are rather disappointing. Suboptimal engraftment, poor cell survival and uncontrolled differentiation may be the reasons behind dismal results. Clearly, new direction is needed and we postulate that with recent progress in biomaterials and bioprinting, regenerative approaches for neurological applications may be finally successful. The use of biomaterials aids engraftment of stem cells, protects them from harmful microenvironment and importantly, it facilitates the incorporation of cell-supporting molecules. The biomaterials used in bioprinting (the bioinks) form a scaffold for embedding the cells/biomolecules of interest, but also could be exploited as a source of endogenous contrast or supplemented with contrast agents for imaging. Additionally, bioprinting enables patient-specific customization with shape/size tailored for actual needs. In stroke or traumatic brain injury for example lesions are localized and focal, and usually progress with significant loss of tissue volume creating space that could be filled with artificial tissue using bioprinting modalities. The value of imaging for bioprinting technology is advantageous on many levels including design of custom shapes scaffolds based on anatomical 3D scans, assessment of performance and integration after scaffold implantation, or to learn about the degradation over time. In this review, we focus on bioprinting technology describing different printing techniques and properties of biomaterials in the context of requirements for neurological applications. We also discuss the need for in vivo imaging of implanted materials and tissue constructs reviewing applicable imaging modalities and type of information they can provide. Statement of Significance: Current stem cell-based regenerative strategies for neurological diseases are ineffective due to inaccurate engraftment, low cell viability and suboptimal differentiation. Bioprinting and embedding stem cells within biomaterials at high precision, including building complex multi-material and multi-cell type composites may bring a breakthrough in this field. We provide here comprehensive review of bioinks, bioprinting techniques applicable to application for neurological disorders. Appreciating importance of longitudinal monitoring of implanted scaffolds, we discuss advantages of various imaging modalities available and suitable for imaging biomaterials in the central nervous system. Our goal is to inspire new experimental approaches combining imaging, biomaterials/bioinks, advanced manufacturing and tissue engineering approaches, and stimulate interest in image-guided therapies based on bioprinting.",
keywords = "Bioink, Bioprinting, Brain, Imaging, Stem cells",
author = "Oliveira, {Eduarda P.} and Izabela Malysz-Cymborska and Dominika Golubczyk and Lukasz Kalkowski and Joanna Kwiatkowska and Reis, {Rui L.} and Oliveira, {J. Miguel} and Piotr Walczak",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.actbio.2019.05.006",
language = "English (US)",
journal = "Acta Biomaterialia",
issn = "1742-7061",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Advances in bioinks and in vivo imaging of biomaterials for CNS applications

AU - Oliveira, Eduarda P.

AU - Malysz-Cymborska, Izabela

AU - Golubczyk, Dominika

AU - Kalkowski, Lukasz

AU - Kwiatkowska, Joanna

AU - Reis, Rui L.

AU - Oliveira, J. Miguel

AU - Walczak, Piotr

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Due to increasing life expectancy incidence of neurological disorders is rapidly rising, thus adding urgency to develop effective strategies for treatment. Stem cell-based therapies were considered highly promising and while progress in this field is evident, outcomes of clinical trials are rather disappointing. Suboptimal engraftment, poor cell survival and uncontrolled differentiation may be the reasons behind dismal results. Clearly, new direction is needed and we postulate that with recent progress in biomaterials and bioprinting, regenerative approaches for neurological applications may be finally successful. The use of biomaterials aids engraftment of stem cells, protects them from harmful microenvironment and importantly, it facilitates the incorporation of cell-supporting molecules. The biomaterials used in bioprinting (the bioinks) form a scaffold for embedding the cells/biomolecules of interest, but also could be exploited as a source of endogenous contrast or supplemented with contrast agents for imaging. Additionally, bioprinting enables patient-specific customization with shape/size tailored for actual needs. In stroke or traumatic brain injury for example lesions are localized and focal, and usually progress with significant loss of tissue volume creating space that could be filled with artificial tissue using bioprinting modalities. The value of imaging for bioprinting technology is advantageous on many levels including design of custom shapes scaffolds based on anatomical 3D scans, assessment of performance and integration after scaffold implantation, or to learn about the degradation over time. In this review, we focus on bioprinting technology describing different printing techniques and properties of biomaterials in the context of requirements for neurological applications. We also discuss the need for in vivo imaging of implanted materials and tissue constructs reviewing applicable imaging modalities and type of information they can provide. Statement of Significance: Current stem cell-based regenerative strategies for neurological diseases are ineffective due to inaccurate engraftment, low cell viability and suboptimal differentiation. Bioprinting and embedding stem cells within biomaterials at high precision, including building complex multi-material and multi-cell type composites may bring a breakthrough in this field. We provide here comprehensive review of bioinks, bioprinting techniques applicable to application for neurological disorders. Appreciating importance of longitudinal monitoring of implanted scaffolds, we discuss advantages of various imaging modalities available and suitable for imaging biomaterials in the central nervous system. Our goal is to inspire new experimental approaches combining imaging, biomaterials/bioinks, advanced manufacturing and tissue engineering approaches, and stimulate interest in image-guided therapies based on bioprinting.

AB - Due to increasing life expectancy incidence of neurological disorders is rapidly rising, thus adding urgency to develop effective strategies for treatment. Stem cell-based therapies were considered highly promising and while progress in this field is evident, outcomes of clinical trials are rather disappointing. Suboptimal engraftment, poor cell survival and uncontrolled differentiation may be the reasons behind dismal results. Clearly, new direction is needed and we postulate that with recent progress in biomaterials and bioprinting, regenerative approaches for neurological applications may be finally successful. The use of biomaterials aids engraftment of stem cells, protects them from harmful microenvironment and importantly, it facilitates the incorporation of cell-supporting molecules. The biomaterials used in bioprinting (the bioinks) form a scaffold for embedding the cells/biomolecules of interest, but also could be exploited as a source of endogenous contrast or supplemented with contrast agents for imaging. Additionally, bioprinting enables patient-specific customization with shape/size tailored for actual needs. In stroke or traumatic brain injury for example lesions are localized and focal, and usually progress with significant loss of tissue volume creating space that could be filled with artificial tissue using bioprinting modalities. The value of imaging for bioprinting technology is advantageous on many levels including design of custom shapes scaffolds based on anatomical 3D scans, assessment of performance and integration after scaffold implantation, or to learn about the degradation over time. In this review, we focus on bioprinting technology describing different printing techniques and properties of biomaterials in the context of requirements for neurological applications. We also discuss the need for in vivo imaging of implanted materials and tissue constructs reviewing applicable imaging modalities and type of information they can provide. Statement of Significance: Current stem cell-based regenerative strategies for neurological diseases are ineffective due to inaccurate engraftment, low cell viability and suboptimal differentiation. Bioprinting and embedding stem cells within biomaterials at high precision, including building complex multi-material and multi-cell type composites may bring a breakthrough in this field. We provide here comprehensive review of bioinks, bioprinting techniques applicable to application for neurological disorders. Appreciating importance of longitudinal monitoring of implanted scaffolds, we discuss advantages of various imaging modalities available and suitable for imaging biomaterials in the central nervous system. Our goal is to inspire new experimental approaches combining imaging, biomaterials/bioinks, advanced manufacturing and tissue engineering approaches, and stimulate interest in image-guided therapies based on bioprinting.

KW - Bioink

KW - Bioprinting

KW - Brain

KW - Imaging

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=85065539411&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065539411&partnerID=8YFLogxK

U2 - 10.1016/j.actbio.2019.05.006

DO - 10.1016/j.actbio.2019.05.006

M3 - Review article

C2 - 31075514

AN - SCOPUS:85065539411

JO - Acta Biomaterialia

JF - Acta Biomaterialia

SN - 1742-7061

ER -